Exercise Supervision Duration and Adherence in Obese Women
Effects Of 6- Versus 12-Week Supervised Multimodal Exercise on Health Outcomes and Adherence in Obese Women: A Pilot Study
1 other identifier
interventional
21
1 country
1
Brief Summary
Obesity is one of the most common health problems worldwide and is associated with many chronic diseases. Regular physical activity is known to play an important role in weight control, balance, quality of life, and mental health. However, obese individuals often have low adherence to exercise programs, and long-term maintenance of physical activity remains a major challenge. Previous studies have shown that supervised exercise programs are effective in improving functional capacity and psychological well-being. On the other hand, home-based programs are less costly and more accessible, but adherence and effectiveness may be limited without professional supervision. To date, there is limited evidence on the optimal supervision duration needed to achieve sustainable improvements in obese women. In the present study, it is aimed to investigate the effects of a 12-week individualized multimodal exercise program with different supervision durations (6 weeks supervised + 6 weeks home-based vs. 12 weeks fully supervised) on adherence and health outcomes in obese women. It is thought that prolonged supervision may increase exercise adherence, improve balance and functional performance, reduce depressive symptoms, and contribute positively to the quality of life. The results of this study may guide the design of future exercise programs for obesity management and provide evidence for more effective and sustainable rehabilitation approaches.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 23, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 18, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 18, 2023
CompletedFirst Submitted
Initial submission to the registry
August 25, 2025
CompletedFirst Posted
Study publicly available on registry
September 3, 2025
CompletedSeptember 3, 2025
September 1, 2025
1.2 years
August 25, 2025
September 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Exercise adherence
Adherence to the exercise program was assessed by the percentage of completed exercise sessions recorded in exercise diaries (participant-reported), attendance checklists maintained by the supervising physiotherapist during supervised sessions, and weekly telephone follow-up logs during the home-based phase (weeks 7-12 for Group 1).
12 weeks
Secondary Outcomes (3)
Functional lower extremity strength
Baseline, 6 weeks, 12 weeks
Balance
Baseline, 6 weeks, 12 weeks
Aerobic exercise capacity
Baseline, 6 weeks, 12 weeks
Other Outcomes (3)
Health-related quality of life
Baseline, 6 weeks, 12 weeks
Depressive symptoms
Baseline, 6 weeks, 12 weeks
Physical activity level
Baseline, 6 weeks, 12 weeks
Study Arms (2)
Group 1= 6-week supervised plus 6-week home-based program
OTHERParticipants perform a 12-week multimodal exercise program targeting balance, muscular strength, core endurance, and cardiovascular fitness. Weeks 1-6 are supervised; weeks 7-12 are home-based via a video catalogue. Walking ≥30 min on ≥2 non-training days is encouraged.
Group 2= Fully supervised 12-week program
OTHERParticipants perform a fully supervised 12-week multimodal exercise program including warm-up, balance, aerobic, strength, and core exercises. Walking ≥30 min on ≥2 non-training days is included.
Interventions
The 12-week program targets balance, muscular strength, core endurance, and cardiovascular fitness. Weeks 1-6 are supervised; weeks 7-12 are home-based via a video catalogue. Walking ≥30 min on ≥2 non-training days is advised. Intensity, repetitions, and sets are individualized using Borg CR-6-20. Adherence is monitored via exercise diaries and weekly phone calls with adjustments as needed.
The 12-week program is fully supervised and includes warm-up, balance, aerobic, strength, and core exercises. Walking ≥30 min on ≥2 non-training days is included. Intensity, repetitions, and sets are individualized using Borg CR-6-20. Adherence is monitored by a physiotherapist using exercise diaries.
Eligibility Criteria
You may qualify if:
- Age between 18 and 60 years
- Body mass index (BMI) \> 30 kg/m²
You may not qualify if:
- Clinically unstable cardiopulmonary disease (e.g., recent myocardial infarction, unstable angina)
- Musculoskeletal or neuromuscular disorders
- Cognitive impairments that could limit exercise participation
- Use of medications affecting bone metabolism
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pamukkale University
Denizli, Denizli, 20160, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc.Prof.
Study Record Dates
First Submitted
August 25, 2025
First Posted
September 3, 2025
Study Start
September 23, 2022
Primary Completion
December 18, 2023
Study Completion
December 18, 2023
Last Updated
September 3, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share